NEW YORK (GenomeWeb News) – Response Genetics today announced it is joining Blue Shield of California's provider network, giving members of the health plan access to the Los Angeles-based molecular diagnostic firm's test portfolio.

The deal is Response Genetics' first contract with an affiliate of Blue Cross Blue Shield. Blue Shield of California has about 3 million members.

Among the products offered by Response Genetics are tests for colon, lung, gastric, and melanoma cancers, as well as tests for the detection of EGFR mutations, KRAS mutations, and others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.